I last reviewed Broadridge Financial Solutions (BR) in this November 29, 2022 post at which time it had recently released its Q1 2022 results. With the release of the Q4 and FY2023 results and FY2024 guidance, I take this opportunity to revisit this existing holding. Business Overview BR operates in two reportable segments, Investor Communication [...]
Between early May and mid-July, investors had a window of opportunity to acquire reasonably valued Broadridge (BR) shares; I added to my exposure on May 9 @ $138.43 in a 'Core' account in the FFJ Portfolio. On August 12, however, BR released its Q4 and FY2022 results and in my post of the same date, [...]
My last Broadridge Financial Solutions (BR) review was on May 11, 2022. At the time I considered its valuation to be attractive so I added to my exposure @ $138.43/share in a 'Core' account within the FFJ Portfolio. Now, however, Broadridge's window of opportunity is closed. Now that BR has released Q4 and FY2022 results [...]
Following my February 2, 2022 post in which I deemed Broadridge (BR) to be reasonably valued based on Q2 and YTD results released on February 1, 2022, BR's share price has tumbled to ~$138. BR has also released Q3 and YTD results on May 3, 2022 which includes a slight increase in the lower end [...]
After an attractive share price pullback and the release of Q2 and YTD results on February 1, 2022, Broadridge (BR) is reasonably valued. In my December 4, 2021 Broadridge Financial Solutions (BR) stock analysis I conclude that: 'As recently as late October, BR's share price was ~$185. Based on current FY2022 earnings estimates from 8 [...]
On May 5, 2021, I wrote a Broadridge Financial Solutions (BR) stock analysis. For whatever reason, I decided to keep it in 'draft' format and completely forgot about it; at the time, BR had just reported Q3 2021 results. Fast forward to December 4, 2021, and BR is currently in Q2 2022; the company's fiscal [...]
Broadridge Financial Solutions, Inc. (BR) is a capital light business in which ~65% of its revenue is recurring. It has a track record of generating strong Free Cash Flow (FCF) although the second half of the fiscal year is when BR generates the bulk of its annual FCF. The bulk of a BR investor's long-term [...]
I recently disclosed that I have initiated a position in Stryker Corporation (SYK). I have a long-term positive outlook on the company but am not ruling out the potential for a broad market pullback which would likely result in a drop in SYK's share price. In this brief article I explain the option trade I [...]
Stryker Corporation (SYK) has disclosed its intent to acquire Wright Medical Group Inc. (WMGI) with a closing schedule for September 30, 2020. Although this acquisition is larger than the several acquisitions SYK has successfully completed in recent years, I fully expect SYK will achieve the targets it expects to achieve with the acquisition. I expect [...]
Broadridge Financial Solutions, Inc. (BR) released Q1 2020 results and reiterated FY2020 guidance on November 6, 2019. At the time of my August 7, 2019 article I suggested investors might want to wait for BR's share price to pullback further before acquiring shares. With the pullback on November 6th I have taken the opportunity to [...]
